急性淋巴细胞白血病:关于治疗和巴西前景的最新情况
Bruno Terra Correa1,2, Gabriela Sales Serra Silva1, Webert Joaquim Silva Mendes1
1Ciências Biológicas e da Saúde, Universidade Estadual de Santa Cruz, Ilhéus, Brazil.
Frontiers in oncology
|March 2, 2026
概括
儿童急性淋巴细胞白血病 (ALL) 是一个重要的全球健康问题. 治疗方面的进步提供了希望,但获得机会的差距仍然存在,特别是在巴西等发展中国家.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 公共卫生 公共卫生
背景情况:
- 急性淋巴细胞白血病 (ALL) 是全球最常见的儿科癌症.
- 存在显著的生存差异,特别是在发展中国家,与社会经济和医疗保健准入不平等有关.
研究的目的:
- 提供关于ALL流行病学,诊断,预后和治疗的最新概述.
- 为儿童ALL提供一个特定的巴西视角,总结国家研究结果.
主要方法:
- 关于ALL诊断和治疗的当前文献的综述.
- 对巴西研究结果的分析,重点关注儿科ALL.
- 在诊断中纳入免疫类型,细胞遗传学和分子生物学.
主要成果:
- 诊断已经先进,集成的分子和遗传技术用于精确的患者分层.
- 治疗已经演变为多阶段方案,包括免疫疗法和CAR T细胞疗法,改善复发/耐药病例的结果.
- 在低收入和中等收入国家,获得先进治疗方法仍然是一个重大挑战.
结论:
- 了解巴西的国家现实对于改善儿科ALL护理至关重要.
- 加强对诊断,新疗法和本地研究的准入至关重要.
- 需要投资制药,以改善儿科ALL患者的生存率和生活质量.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Bone Marrow Sampling and Transplants
1.9K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.9K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K


